Login / Signup
Ece Erbağcı
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 5
Top Topics
Replacement Therapy
Patient Reported
Respiratory Syndrome Coronavirus
Cross Sectional
Top Venues
Journal of cosmetic dermatology
Journal of cutaneous pathology
The Australasian journal of dermatology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Sema Koç Yıldırım
,
Ece Erbağcı
,
Aslı Hapa
Omalizumab treatment in combination with any other biologics: Is it really a safe duo?
The Australasian journal of dermatology
(2023)
Sema Koç Yıldırım
,
Ece Erbağcı
,
Neslihan Demirel Öğüt
Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?
Journal of cosmetic dermatology
21 (5) (2022)
Sema Koç Yıldırım
,
Neslihan Demirel Öğüt
,
Ece Erbağcı
Retrospective evaluation of patients with chronic spontaneous urticaria using omalizumab during the COVID-19 pandemic.
Journal of cosmetic dermatology
21 (2) (2022)
Ece Erbağcı
,
Ayşen Karaduman
,
Özay Gököz
,
Sibel Ersoy Evans
Merkel cell number and distribution, and CD200 expression in patients with lichen planopilaris and discoid lupus erythematosus.
Journal of cutaneous pathology
49 (12) (2022)
Ece Erbağcı
,
Neslihan Demirel Öğüt
,
Sema Koç Yıldırım
,
Fatma Aslı Hapa
Is dupilumab effective in adult-onset atopic dermatitis: Real-life experience of 16 patients.
Journal of cosmetic dermatology
21 (10) (2022)